{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:50:00Z","timestamp":1792698600199,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021081","name":"European Rare Kidney Disease Reference Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NW26-06-00299"],"award-info":[{"award-number":["NW26-06-00299"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["IN 00023001"],"award-info":[{"award-number":["IN 00023001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trre.2026.101006","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:11:25Z","timestamp":1771891885000},"page":"101006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular diagnostics in HLA-incompatible kidney transplantation"],"prefix":"10.1016","volume":"40","author":[{"given":"Miray","family":"Guney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101006_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/193724","article-title":"Antibody-mediated rejection in kidney transplantation: a review","volume":"2012","author":"Puttarajappa","year":"2012","journal-title":"J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/TP.0000000000000959","article-title":"The challenge of acute antibody-mediated rejection in kidney transplantation","volume":"100","author":"Chehade","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101006_bb0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.humimm.2016.10.009","article-title":"Kidney transplantation of highly sensitized recipients under the new kidney allocation system: a reflection from five different transplant centers across the United States","volume":"78","author":"Parsons","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2026.101006_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101006_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the management of kidney transplant patients with HLA antibodies: by the European society for organ transplantation working group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101006_bb0040","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.ekir.2024.07.024","article-title":"Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor","volume":"9","author":"Kamar","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.trre.2026.101006_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11244","article-title":"Imlifidase for kidney transplantation of highly sensitized patients with a positive crossmatch: the French consensus guidelines","volume":"36","author":"Couzi","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101006_bb0050","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrneph.2016.85","article-title":"Molecular assessment of disease states in kidney transplant biopsy samples","volume":"12","author":"Halloran","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2026.101006_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14312","article-title":"12-month outcomes of a prospective randomized trial investigating effects of IVIG on top of rATG versus rATG alone in pre-sensitized kidney transplant recipients: the INHIBIT study","volume":"38","author":"Viklicky","year":"2025","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101006_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: insights from the MMDx project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101006_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11321","article-title":"The clinical utility of post-transplant monitoring of donor-specific antibodies in stable renal transplant recipients: a consensus report with guideline statements for clinical practice","volume":"36","author":"van den Broek","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101006_bb0075","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.3389\/ti.2023.12115","article-title":"European Society of Organ Transplantation Consensus Statement on testing for non-invasive diagnosis of kidney allograft rejection","volume":"36","author":"Park","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101006_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101006_bb0085","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1600-6143.2009.02701.x","article-title":"Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations","volume":"9","author":"Kraus","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1600-6143.2006.01657.x","article-title":"Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts","volume":"7","author":"Haas","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ctr.12766","article-title":"Early subclinical inflammation correlates with outcomes in positive crossmatch kidney allografts","volume":"30","author":"Dean","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0100","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1600-6143.2007.01979.x","article-title":"Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study","volume":"7","author":"Rush","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0105","article-title":"Protocol biopsy after kidney transplant: clinical application and efficacy to detect allograft rejection","volume":"15","author":"Moein","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.trre.2026.101006_bb0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.ackd.2016.09.002","article-title":"Protocol biopsies: utility and limitations","volume":"23","author":"Huang","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trre.2026.101006_bb0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1600-6143.2006.01677.x","article-title":"Protocol biopsies in renal transplantation: insights into patient management and pathogenesis","volume":"7","author":"Mengel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00000478-200306000-00012","article-title":"International variation in histologic grading is large, and persistent feedback does not improve reproducibility","volume":"27","author":"Furness","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trre.2026.101006_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101006_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2026.101006_bb0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0150","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/ajt.17136","article-title":"Microvascular inflammation: gene expression changes do not necessarily reflect pathogenesis","volume":"22","author":"Naesens","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000517259","article-title":"Recurrent glomerular diseases in renal transplantation with focus on role of Electron microscopy","volume":"1","author":"Seshan","year":"2021","journal-title":"Glomerular Dis"},{"key":"10.1016\/j.trre.2026.101006_bb0160","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3389\/fimmu.2019.01944","article-title":"Recurrent and de novo glomerulonephritis after kidney transplantation","volume":"10","author":"Lim","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2026.101006_bb0165","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/ajt.15752","article-title":"Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies","volume":"20","author":"Madill-Thomsen","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0170","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ajt.2025.04.025","article-title":"Molecular diagnosis of kidney allograft rejection based on the Banff human organ transplant gene panel: a multicenter international study","volume":"25","author":"Zielinski","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajt.2024.07.034","article-title":"Subthreshold rejection activity in many kidney transplants currently classified as having no rejection","volume":"25","author":"Halloran","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0180","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001741","article-title":"Transcriptomic signatures of antibody-mediated rejection in early biopsies with negative histology in HLA-incompatible kidney transplantation","volume":"11","author":"Hruba","year":"2025","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2026.101006_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65153-9","article-title":"Continuous indices to assess the phenotypic spectrum of kidney transplant rejection","volume":"16","author":"Vaulet","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2026.101006_bb0190","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/ajt.16059","article-title":"Banff 2019 meeting report: molecular diagnostics in solid organ transplantation-consensus for the Banff human organ transplant (B-HOT) gene panel and open source multicenter validation","volume":"20","author":"Mengel","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94197","article-title":"Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes","volume":"2","author":"Reeve","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.trre.2026.101006_bb0200","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0205","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ajt.14600","article-title":"Review: the transcripts associated with organ allograft rejection","volume":"18","author":"Halloran","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ki.2014.75","article-title":"Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies","volume":"86","author":"Hayde","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of Felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101006_bb0220","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001237","article-title":"Absolute or relative quantification of donor-derived cell-free DNA in kidney transplant recipients: case series","volume":"7","author":"Osmanodja","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2026.101006_bb0230","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2026.101006_bb0235","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/ndt\/gfae282","article-title":"Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial","volume":"40","author":"Akifova","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0240","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.kint.2024.09.023","article-title":"Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients","volume":"107","author":"Budde","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/FTD.0000000000001023","article-title":"Donor-derived cell-free DNA for personalized immunosuppression in renal transplantation","volume":"45","author":"Oellerich","year":"2023","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2026.101006_bb0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001685","article-title":"Targeting CD38 in subclinical antibody-mediated rejection in HLA-incompatible kidney transplantation: a case report","volume":"10","author":"Viklicky","year":"2024","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2026.101006_bb0260","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.ekir.2025.07.009","article-title":"Anti-CD38 daratumumab treatment of chronic active antibody-mediated kidney allograft rejection","volume":"10","author":"Lye","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.trre.2026.101006_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208207","article-title":"Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay","volume":"13","author":"Gielis","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.trre.2026.101006_bb0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ndt\/gfad120","article-title":"Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function","volume":"39","author":"Cucchiari","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajt.2025.08.036","article-title":"2025 report of the sensitization in transplantation: assessment of risk working group on donor-derived cell-free DNA: establishing analytical validity as the basis for appropriate and effective clinical utilization","volume":"26","author":"Valenzuela","year":"2026","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0280","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.kint.2024.10.029","article-title":"Using donor-derived cell-free DNA in kidney transplant patients: this jury needs more evidence","volume":"107","author":"Seif","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.kint.2025.01.039","article-title":"Simply measuring what matters-toward clinical utility of donor-derived cell-free DNA testing?","volume":"107","author":"Naesens","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101006_bb0290","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101006_bb0295","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1681\/ASN.2020060850","article-title":"Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection","volume":"32","author":"El Fekih","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2026.101006_bb0300","article-title":"Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients","volume":"14","author":"Seo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2026.101006_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1154650","article-title":"Physiopathological role of extracellular vesicles in alloimmunity and kidney transplantation and their use as biomarkers","volume":"14","author":"Cuadrado-Payan","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2026.101006_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathol.2023.10.004","article-title":"Exosomes and microvesicles in kidney transplantation: the long road from trash to gold","volume":"56","author":"Ramalhete","year":"2024","journal-title":"Pathology"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:37:38Z","timestamp":1777595858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0955470X26000169"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101006","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular diagnostics in HLA-incompatible kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101006"}}